2024 Business School Applications Skyrocket amidst Economic Uncertainty
October 23, 2024
GMAC’s annual survey shows demand growth is five times greater than the pandemic boom RESTON, Va., Oct. 23, 2024 (GLOBE
Category: Press Releases
En 2024, le nombre des candidatures aux écoles de commerce monte en flèche dans un contexte d’incertitude économique
October 23, 2024
L’enquête annuelle du GMAC révèle que la croissance de la demande est cinq fois supérieure à l’augmentation observée pendant la
EBC Financial Group and the University of Oxford’s Department of Economics Announce WERD Episode on Macroeconomics and Climate
October 23, 2024
Balancing Economic Growth and Climate Resilience: A Global Discussion OXFORD, United Kingdom, Oct. 23, 2024 (GLOBE NEWSWIRE) — EBC Financial
Quantexa é reconhecida como líder de categoria no RiskTech Quadrant® para soluções KYC (Know Your Customer)
October 22, 2024
A Quantexa obteve a melhor classificação no Relatório RiskTech100® 2025, destacando sua força e capacidade de inovação no crescente mercado
La plateforme Quantexa reconnue leader de sa catégorie dans le RiskTech Quadrant® pour ses solutions de connaissance du client
October 22, 2024
La plateforme Quantexa a obtenu une place de choix dans le rapport RiskTech100® 2025, soulignant ainsi sa force et son
Incrível, Jeff! A IriusRisk apresenta uma ferramenta com tecnologia de IA que pode gerar modelos de ameaças com base em imagens
October 22, 2024
Incrível, Jeff! A IriusRisk apresenta uma ferramenta com tecnologia de IA que pode gerar modelos de ameaças com base em
Recursion announces first patient dosed in Phase 2 clinical study of REC-3964, a potential first-in-class, oral, non-antibiotic small molecule for recurrent Clostridioides difficile infection
October 22, 2024
REC-3964 is Recursion’s first new chemical entity developed using the RecursionOS. REC-3964 represents a novel, non-antibiotic approach with a unique
Recursion announces first patient dosed in Phase 2 clinical study of REC-3964, a potential first-in-class, oral, non-antibiotic small molecule for recurrent Clostridioides difficile infection
October 22, 2024
REC-3964 is Recursion’s first new chemical entity developed using the RecursionOS. REC-3964 represents a novel, non-antibiotic approach with a unique
Recursion announces first patient dosed in Phase 2 clinical study of REC-3964, a potential first-in-class, oral, non-antibiotic small molecule for recurrent Clostridioides difficile infection
October 22, 2024
REC-3964 is Recursion’s first new chemical entity developed using the RecursionOS. REC-3964 represents a novel, non-antibiotic approach with a unique
Incroyable Jeff ! IriusRisk présente un outil basé sur l’IA capable de générer des modèles de menaces à partir d’images
October 22, 2024
La plateforme de modélisation des menaces lance « Jeff : Assistant IA », une première mondiale en termes de création
Incroyable Jeff ! IriusRisk présente un outil basé sur l’IA capable de générer des modèles de menaces à partir d’images
October 22, 2024
La plateforme de modélisation des menaces lance « Jeff : Assistant IA », une première mondiale en termes de création
Incroyable Jeff ! IriusRisk présente un outil basé sur l’IA capable de générer des modèles de menaces à partir d’images
October 22, 2024
La plateforme de modélisation des menaces lance « Jeff : Assistant IA », une première mondiale en termes de création
Recent Posts
President Joo Louren§o Participates in Alamein Africa-GO63 Forum
October 3, 2026
President Joo Louren§o Advocates for Empowerment of AUDA-NEPAD
October 3, 2026
Angola Strengthens Mpox Prevention Along Border with DRC
October 2, 2026
Angola’s Pension Fund Assets Reach 1.33 Trillion Kwanzas in 2026
October 2, 2026
